Arcutis Biotherapeutics (ARQT) Other financing activities (2019 - 2026)

Arcutis Biotherapeutics' Other financing activities history runs 8 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Other financing activities rose 170.13% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $5.3 million (up 160.07% YoY), while the FY2025 annual figure was $4.6 million, up 168.36% from the prior year.
• Other financing activities for Q1 2026 stood at $1.1 million, down from $3.3 million in the prior quarter.
• The five-year high for Other financing activities was $3.3 million in Q4 2025, with the low at $16000.0 in Q4 2022.
• The 5-year median for Other financing activities is $328000.0 (2022), against an average of $602500.0.
• The sharpest annual moves came in 2022 and 2023: Other financing activities slumped 96.13% in 2022, then soared 3512.5% in 2023.
• Arcutis Biotherapeutics' Other financing activities stood at $16000.0 in 2022, then soared by 1187.5% to $206000.0 in 2023, then soared by 416.5% to $1.1 million in 2024, then surged by 208.08% to $3.3 million in 2025, then tumbled by 67.45% to $1.1 million in 2026.
• Business Quant data shows ARQT's Other financing activities at $1.1 million in Q1 2026, $3.3 million in Q4 2025, and $863000.0 in Q3 2025.